Evaluation of Nanosuspensions for Absorption Enhancement of Poorly Soluble Drugs: In Vitro Transport Studies Across Intestinal Epithelial Monolayers
Journal Title: The AAPS Journal - Year 2008, Vol 10, Issue 3
Abstract
Budesonide and spironolactone nanosuspensions type DissoCubes® were manufactured by high-pressure piston gap homogenization (Emulsiflex®-C50, Avestin Inc, Ottawa, Canada). Budesonide nanosuspension consisted of 10% budesonide, 5% Octosol 449 (potassium oleate) and 85% water. Spironolactone nanosuspension type DissoCubes® consisted of 10% spironolactone, 0.5% Octowet70 PG (sodium dioctyl sulfosuccinate) and 89.5% water. The mean particle diameters in the nanosuspensions were 581 nm for budesonide and 515 nm for spironolactone, respectively (PCS, Zetasizer 3000 HS Malvern Instruments Ltd, UK).
Authors and Affiliations
T. Lenhardt, G. Vergnault, P. Grenier, D. Scherer, P. Langguth
Keywords
Related Articles
- EP ID EP681626
- DOI 10.1208/s12248-008-9050-7
- Views 84
- Downloads 0
Pharmacogenomics: The promise of personalized medicine
Paracellular Tightness and Claudin-5 Expression is Increased in the BCEC/Astrocyte Blood–Brain Barrier Model by Increasing Media Buffer Capacity During Growth
Most attempts to develop in vitro models of the blood–brain barrier (BBB) have resulted in models with low transendothelial electrical resistances (TEER), as compared to the native endothelium. The aim of the pre...
Microparticles for Inhalational Delivery of Antipseudomonal Antibiotics
Chronic pseudomonal bronchopulmonary infections in cystic fibrosis patients are frequently controlled with inhaled antibiotics. Dry-powder inhalable antibiotics are an attractive alternative to nebulized medications. We...
Effect of Cyclosporine and Rifampin on the Pharmacokinetics of Macitentan, a Tissue-Targeting Dual Endothelin Receptor Antagonist
Macitentan is a dual endothelin receptor antagonist under phase 3 investigation in pulmonary arterial hypertension. We investigated the effect of cyclosporine (Cs) and rifampin on the pharmacokinetics of macitentan and i...
Poly(butylcyanoacrylate) and Poly(ε-caprolactone) Nanoparticles Loaded with 5-Fluorouracil Increase the Cytotoxic Effect of the Drug in Experimental Colon Cancer
The clinical use of 5-fluorouracil, one of the drugs of choice in colon cancer therapy, is limited by a nonuniform oral absorption, a short plasma half-life, and by the development of drug resistances by malignant cells....